Vital Images and Toshiba renew agreement

Article

Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice

Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice to customers purchasing its Aquilion multidetector CTs. The new agreement includes a minimum worldwide revenue commitment from Toshiba of more than $5 million and is effective through Sept. 30, 2003. It can be renewed with the mutual consent of Vital Images and Toshiba.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.